- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04411186
A Trial of Adding Lung Protective Strategies to Existing Enhanced Recovery After Surgery (ERAS) Protocols and Its Effects on Improving Post-Operative Lung Function
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Medical University of South Carolina
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All subjects going for scheduled colorectal or hepatobiliary surgery at the MUSC ART hospital who would normally be utilizing the existing ERAS protocols
- English speaking
- Able to give informed consent
- Ages 18 years and older
Exclusion Criteria:
- Emergency cases
- Pregnant subjects-confirmed by pre-operative urine pregnancy test
- Subjects with unique lung pathologies including, but not limited to: advanced pulmonary fibrosis, lung transplantation recipients, end stage COPD, pulmonary Hypertension
- Subjects on home O2
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Standard Enhanced Recovery After Surgery (ERAS) Protocol
Control for this study will be the standard MUSC ERAS protocol - fluid intake, hydration, anti-emetics, pain control, and several other considerations.
|
Subjects receive standard MUSC ERAS protocol - fluid intake, hydration, anti-emetics, pain control, and several other considerations.
|
Experimental: ERAS and 5 Lung Protective Interventions
The standard MUSC ERAS protocol - fluid intake, hydration, anti-emetics, pain control, and several other considerations. The subject will also receive the following lung protective interventions:
|
Subjects will receive the standard MUSC ERAS protocol - fluid intake, hydration, anti-emetics, pain control, and several other considerations. The subject will also receive the following lung protective interventions: Pressure control ventilation-volume guaranteed (PCV-VG) ventilation at approximately 7cc/kg of predicted body weight (derived from combination of sex and height) Positive end-expiratory pressure (PEEP) 7cm H2O5 Immediately post intubation recruitment breath (30cm water for 30 seconds) Every 1 hour recruitment breath (30cm water for 30 seconds) 40% FIO2 initially - titrate up as necessary to maintain SPO2 >94% |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Inspiratory Capacity
Time Frame: 2 hours
|
The primary outcome of interest is the inspiratory capacity obtained in the PACU via the incentive spirometer.
|
2 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Oxygen Saturation (SPO2) Trends
Time Frame: 2 hours
|
numerical value for SPO2 trends in 15 min intervals in the Post Operative Care Unit (PACU)
|
2 hours
|
Incidence of supplemental Oxygen Requirements
Time Frame: 2 hours
|
Recording of use or lack thereof of supplemental oxygen in PACU in 15 minute intervals.
|
2 hours
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Pro00094011
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colorectal Surgery
-
Gulhane School of MedicineUniversity Hospital, Ghent; Szeged University; University Clinical Centre of... and other collaboratorsCompletedColorectal Disorders | Colorectal SurgeryTurkey
-
York Teaching Hospitals NHS Foundation TrustCompletedColorectal Surgery | Major Abdominal SurgeryUnited Kingdom
-
IHU StrasbourgRecruitingColorectal SurgeryFrance
-
Indiana UniversityCompletedColorectal SurgeryUnited States
-
Wake Forest University Health SciencesWithdrawnColorectal Surgery
-
University of Massachusetts, WorcesterCompleted
-
Helsinki University Central HospitalActive, not recruiting
-
Children's Hospital Medical Center, CincinnatiTerminated
-
York Teaching Hospitals NHS Foundation TrustTerminatedColorectal SurgeryUnited Kingdom
-
Bnai Zion Medical CenternovoGICompleted
Clinical Trials on Standard Enhanced Recovery After Surgery (ERAS) Protocol
-
Instituto Brasileiro de Controle do CancerRecruitingGynecologic Cancer | Enhanced Recovery After SurgeryBrazil
-
Alexandria UniversityCompletedSurgery | Lumbar Spine Disease | ERAS | Non Insulin Dependent Diabetes MellitusEgypt
-
Hartford HospitalCompleted
-
Fudan UniversityUnknownColorectal SurgeryChina
-
Instituto Brasileiro de Controle do CancerWithdrawnEnhanced Recovery After Surgery | Gynecologic Surgical ProceduresBrazil
-
The Second Hospital of Shandong UniversityRecruitingLung Cancer | Surgery | ERASChina
-
University of Colorado, DenverRecruitingEnhanced Recovery After Surgery | Gynecologic DiseaseUnited States
-
University Hospital, GrenobleCompleted
-
University Hospital, Clermont-FerrandMinistry of Health, France; Direction Générale de l'Offre de SoinsUnknown
-
Assiut UniversityNot yet recruitingEsophageal Diseases | Esophagostomy Complication